Updates are available Correction dated 2021-02-12

Article History

Accepted: 21 October 2020

First Online: 19 January 2021

Change Date: 12 February 2021

Change Type: Correction

Change Details: A Correction to this paper has been published:

Change Details: https://doi.org/10.1007/s40271-021-00497-0

Declarations

:

: CW is employed by the Meningitis Research Foundation, which has received grants and conference sponsorship from Pfizer, GlaxoSmithKline, and Sanofi Pasteur. Sophie Staniszewska, Edward M. Hill, Richard Grant, Peter Grove, Jarina Porter, Tinevimbo Shiri, Sue Tulip, Jane Whitehurst, Samik Datta, Stavros Petrou, and Matt Keeling these authors declare no conflict of interest.

: MEMVIE was funded by the UK Department of Health and the National Institute for Health Research (NIHR). SS, EMH, SP and MK are supported by the NIHR (Policy Research Programme, Infectious Disease Dynamic Modelling in Health Protection, Grant number 027/0089). SP also receives support as an NIHR Senior Investigator. SS is part funded by the NIHR Applied Research Collaboration (ARC) West Midlands, the NIHR Health Protection Research Unit (HPRU) Gastrointestinal Infections, and the NIHR HPRU Genomics and Enabling data. This report is independent research funded by the NIHR (Policy Research Programme, Infectious Disease Dynamic Modelling in Health Protection, 027/0089). The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

: Not applicable.

: All authors confirm their consent for publication.

: Data sharing was not applicable to this article as no datasets were generated or analysed during this study.

: Not applicable.

: SS: PPI lead for the MEMVIE study. Organised the PPI meetings, facilitated the PPI discussions as knowledge spaces for co-production, contributed expertise on PPI evidence, co-produced the PPI framework, lead author and lead on reviewer responses. EMH: epidemiological modeller who participated in PPI meetings, contributing expertise regarding mathematical modelling and intersections with PPI, co-produced the PPI framework, conceptualised Fig. InternalRef removed, and contributed to writing of the manuscript and responding to reviewer comments. RG: public contributor, contributed experiential expertise to the PPI discussions, co-produced the framework and supporting appendices, and contributed to writing of the manuscript and responding to reviewer comments. PG: policy maker who commissioned the study, supported the exploration of PPI and the capture of its contribution, attended PPI discussions, and contributed to conceptual development, writing of the manuscript and responding to reviewer comments. JP: public contributor, contributed experiential expertise to the PPI discussions, co-produced the framework and supporting appendices, and contributed to writing of the manuscript and responding to reviewer comments. TS: health economic who participated in PPI meetings, contributed expertise regarding economic modelling and intersection with PPI, co-produced the PPI framework, and contributed to writing of the manuscript and responding to reviewer comments. ST: public contributor, contributed experiential expertise to the PPI discussions, co-produced the framework and supporting appendices, and contributed to writing of the manuscript and responding to reviewer comments. JW: public contributor, contributed experiential expertise to the PPI discussions, co-produced the framework and supporting appendices, and contributed to writing of the manuscript and responding to reviewer comments. CW: patient group representative, contributed experiential expertise to the PPI discussions, contributed a broader charity perspective to wider economic discussions, co-produced the framework and supporting appendices, and contributed to writing of the manuscript and responding to reviewer comments. SD: epidemiological modeller who participated in PPI meetings, contributing expertise regarding mathematical modelling and intersections with PPI, co-produced the PPI framework, and contributed to writing of the manuscript and responding to reviewer comments. SP: health economic who participated in PPI meetings, contributed expertise regarding economic modelling and intersection with PPI, co-produced the PPI framework, and contributed to writing of the manuscript and responding to reviewer comments. MK: epidemiological modeller who participated in PPI meetings, contributing expertise regarding mathematical modelling and intersections with PPI, co-produced the PPI framework, and contributed to writing of the manuscript and responding to reviewer comments.